Abella, Michael B.

HRN: 23-74-90  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/30/2026
06/05/2026
IV
650mg
Q6
Urti
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines